2019 EULAR/ACR 系统性红斑狼疮分类标准在早期、不同性别和种族中的表现
结果显示该标准在早期病程、男性、女性及白种、黑种、西班牙裔和亚洲患者中均表现良好,敏感性优于ACR标准,特异性优于SLICC标准。
要点
- 早期病程(1至<3年)患者中,EULAR/ACR标准敏感性优于ACR标准(97% vs 81%)。
- 男性(敏感性93%、特异性96%)和女性(敏感性97%、特异性94%)中均表现良好。
- 西班牙裔和亚洲患者中,EULAR/ACR标准敏感性优于ACR标准(分别为100% vs 86%和97% vs 77%)。
核心结论
- 2019 EULAR/ACR标准在早期病程、男性、女性及白种、黑种、西班牙裔和亚洲患者中均表现良好。
- 该标准在多个亚组中敏感性优于ACR标准,特异性优于SLICC标准。
主要发现
- 队列包括女性1098例、男性172例、亚洲118例、黑种68例、西班牙裔124例、白种941例。
- SLE病程1至<3年者196例,≥5年者879例。
- 病程1至<3年患者中,EULAR/ACR标准敏感性97%,ACR标准81%。
- 男性敏感性93%、特异性96%;女性敏感性97%、特异性94%。
- 女性中EULAR/ACR标准敏感性97%优于ACR标准83%,特异性94%优于SLICC标准82%。
关键数值与推荐
- 早期病程(1至<3年)患者中,EULAR/ACR标准敏感性97%,ACR标准81%。
- 男性敏感性93%、特异性96%;女性敏感性97%、特异性94%。
- 女性中EULAR/ACR标准敏感性97% vs ACR 83%,特异性94% vs SLICC 82%。
- 白种患者中EULAR/ACR标准敏感性95% vs ACR 83%,特异性94% vs SLICC 83%。
- 黑种患者敏感性98%、特异性100%;西班牙裔敏感性100% vs ACR 86%;亚洲敏感性97% vs ACR 77%。
临床怎么用
- 在早期病程、不同性别和种族患者中,可优先使用2019 EULAR/ACR标准进行分类,其敏感性和特异性总体优于既往标准。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) 2019 Classification Criteria for systemic lupus erythematosus (SLE) have been validated with high sensitivity and specificity. We evaluated the performance of the new criteria with regard to disease duration, sex and race/ethnicity, and compared its performance against the Systemic Lupus International Collaborating Clinics (SLICC) 2012 and ACR 1982/1997 criteria. METHODS: Twenty-one SLE centres from 16 countries submitted SLE cases and mimicking controls to form the validation cohort. The sensitivity and specificity of the EULAR/ACR 2019, SLICC 2012 and ACR 1982/1997 criteria were evaluated. RESULTS: The cohort consisted of female (n=1098), male (n=172), Asian (n=118), black (n=68), Hispanic (n=124) and white (n=941) patients; with an SLE duration of 1 to <3 years (n=196) and ≥5 years (n=879). Among patients with 1 to <3 years disease duration, the EULAR/ACR criteria had better sensitivity than the ACR criteria (97% vs 81%). The EULAR/ACR criteria performed well in men (sensitivity 93%, specificity 96%) and women (sensitivity 97%, specificity 94%). Among women, the EULAR/ACR criteria had better sensitivity than the ACR criteria (97% vs 83%) and better specificity than the SLICC criteria (94% vs 82%). Among white patients, the EULAR/ACR criteria had better sensitivity than the ACR criteria (95% vs 83%) and better specificity than the SLICC criteria (94% vs 83%). The EULAR/ACR criteria performed well among black patients (sensitivity of 98%, specificity 100%), and had better sensitivity than the ACR criteria among Hispanic patients (100% vs 86%) and Asian patients (97% vs 77%). CONCLUSIONS: The EULAR/ACR 2019 criteria perform well among patients with early disease, men, women, white, black, Hispanic and Asian patients. These criteria have superior sensitivity than the ACR criteria and/or superior specificity than the SLICC criteria across many subgroups.
引用
- Johnson SR, Brinks R, Costenbader KH, et al. Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities. Ann Rheum Dis. 2020. PMID: 32816709. doi:10.1136/annrheumdis-2020-217162
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。